New Antibiotics
نویسندگان
چکیده
منابع مشابه
Axenomycins, new cestocidal antibiotics.
Axenomycins are a new group of macrolide antibiotics isolated from the fermentation broth of Streptomyces lisandri n.sp. They exhibit anthelmintic activity against tapeworms (Cestoda). Three different fractions, A, B, and D, have been obtained, the most active fraction being axenomycin D. The activities of the axenomycin complex and axenomycin D against Hymenolepis nana in mice, Taenia pisiform...
متن کاملWhat's new in antibiotics?
Antibiotics are important agents in dermatologic practice. New drugs have expanded the therapeutic approach to uncomplicated skin infections and complicated infections involving deeper soft tissue or infections that require surgical intervention. This article reviews new antibiotics of dermatologic importance, including daptomycin (cyclic lipopeptide), linezolid (oxazolidinone), quinupristin-da...
متن کاملGrowing antibiotics resistance and the need for new antibiotics.
Growing antibiotic resistance is a global phenomenon in both developed and developing countries. Methicillin-resistant Staphylococcus aureus (MRSA) alone infects more than 94 000 people and kills nearly 19,000 in the US every year, more deaths than are caused by HIV/AIDS, Parkinson’s disease, emphysema, and homicide combined(1). Penicillin-resistant streptococcal pneumonia and vancomycin resist...
متن کاملCan biotech deliver new antibiotics?
The evolution of support for the discovery and development of antibacterial (or antibiotic) agents from the larger pharmaceutical companies to the entrepreneur-like small biotechnology companies has been an experiment in the making for the past 15 years. The word 'experiment' is precisely chosen as the outcome is not certain. Many of the antibiotic biotech organizations that were most likely to...
متن کاملNew Antibiotics—Resistance Is Futile
PLoS Biology | http://biology.plosjournals.org By next summer, more than 40% of Streptococcus pneumoniae strains in the United States will resist both penicillin and erythromycin, according to a recent prediction from the Harvard School of Public Health. The forecast, based on mathematical modeling, was published in the spring of 2003. It’s too early to tell whether that prediction is precisely...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Infectious Diseases in Obstetrics and Gynecology
سال: 1998
ISSN: 1064-7449,1098-0997
DOI: 10.1002/(sici)1098-0997(1998)6:5<195::aid-idog1>3.0.co;2-6